© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Discovery stories in chemistry can spark curiosity, especially for compounds that leave a big mark in both the laboratory and the world outside it. Maduramicin ammonium traces back to the 1970s, with a rise out of a soil actinomycete, Actinomadura rubra, reflecting a period when agricultural scientists scoured the earth for better answers to coccidiosis in poultry. Scientists noticed birds with access to certain soil types held up against intestinal infections better than others. This set off years of grind in laboratories, resulting in an ionophore that didn’t just handle the expected but often outperformed established drugs of the era. Maduramicin’s success connected to a boom in industrial fermentation, affordable isolation, and a growing need for efficient livestock feed additives as the global demand for poultry soared. The journey from obscure soil sample to commercial product took both persistent research and a strong hunger for solutions in animal health.
Producers today offer maduramicin ammonium as a feed additive, mainly in the fight against coccidiosis in broiler chickens. The compound lands on the market as a white to beige, mostly crystalline powder, designed for easy mixing in factory-scale feed systems. Purity runs high in finished goods, with modern processes chasing down trace byproducts and using robust quality checks to guard against batch-to-batch drift. It enters the supply chain mostly as standard bags or bulk containers, sealed against air and moisture, with clear lot-traceability for farms and feed mills. Operators in agriculture get a tried and tested option with a documented set of benefits, though the narrow safety margin and its potent biological activity put the onus on strict handling practices.
Maduramicin ammonium stands as a polyether ionophore, structurally intricate, with molecules weaving a complex set of rings and functional groups. The powder dissolves slightly in water but has better solubility in organic solvents like methanol and acetone—behavior that informs its extraction and formulation. Its melting point holds steady above 175°C, and the compound resists degradation until exposed to strong acids, bases, or oxidants, making it robust enough for most feed-processing conditions. Its specific optical rotation helps analysts spot possible adulteration, and its bulk density numbers shape commercial blending. Chemical stability stays strong in finished feed for weeks if kept away from heat and light, and the distinct odor, faint but unmistakable, signals proper identity to an experienced handler.
Manufacturers publish exhaustive datasheets, listing minimum content standards, target homogeneity levels in finished feeds, particle size distribution, and identity verification through chromatography and spectroscopic signatures. Regulatory agencies, especially in the EU and China, keep strict limits not just for the active ingredient but for allowed residues in edible animal tissue. Product labels must call out not only the maduramicin ammonium content per kilogram, but also storage instructions, withdrawal periods, compatible feed ingredients, and the legal claims permitted for species and ages of target animals. Mill operators get detailed mixing charts and precautionary tales, since over- or under-dosing carries expensive public health or production risks. Failure to match labeling with real chemical content can result in recalls, trade bans, or criminal liability, keeping pressure on every link of the distribution chain.
Standard production depends on submerged aerobic fermentation of the producing actinomycete, crafted after years of strain optimization. Vats churn with a carbon-rich broth, pH monitored, aeration kept steady, and antifoam strategies tweaked as the microbe pumps out the parent compound. Harvest begins after several days, with filtration to catch the mycelium and extract the crude product. A battery of solvent-based purifications follows, usually crystallizing maduramicin as its ammonium salt for commercial uses. Downstream technicians focus on maximizing yield and purity while minimizing off-flavors, colored impurities, and non-target residues. Final blending incorporates stabilizers and flow agents to make a product sturdy enough for global logistics and months in on-farm bins.
The polyether backbone of maduramicin opens a door for selective modifications. Chemists searching for new or improved molecules tinker with esterification, amidation, or simple salt substitutions, aiming for better pharmacokinetics or greater spectrum against protozoal targets. The basic ammonium salt dominates the animal health market because it balances feed stability and biological potency. Some research groups have explored prodrug approaches, linking maduramicin’s core to carrier molecules for controlled release or site-specific action. Metabolic studies focus on how animal guts split the molecule, seeking clues not just for drug action but for how to keep residues out of eggs and meat. Despite many attempts, no modification has yet bested the original ammonium version for on-farm use.
Maduramicin finds itself listed under several synonyms, reflecting both chemical precision and branding choices. Beyond “maduramicin ammonium,” the technical literature refers to it simply as maduramycin, maduramicin A, or sometimes by legacy fermentation code numbers. On the commercial side, companies sell it under names like Coxiril®, Cycostat®, or Madurax®, with region-specific brands filling shelves in Latin America, Southeast Asia, and the Middle East. Global harmonization of nomenclature lags behind, so professionals pay close attention to CAS numbers and registration data to ensure cross-border communication avoids toxic confusion.
Maduramicin’s power as an anticoccidial comes at a price. Feed mills and farm staff get extensive safety briefings, gloves and dust masks encouraged even at low-exposure sites. Mistakes in blending or storage have documented links to accidental poisonings in non-target species, especially horses and turkeys, and even brief off-label use triggers regulatory investigations. Human contact, by skin or inhalation, can irritate or sensitize exposed workers. National guidelines outline emergency procedures for spills, and regular training forms a backbone of risk mitigation. On-farm, special attention falls on withdrawal times before poultry slaughter, avoiding maduramicin residues in meat that would offend both regulators and consumers. Feed suppliers run quality control analytics every shift, aiming to stamp out both accidental overdosing and dilution with inferior or illegal alternatives.
Maduramicin ammonium dominates as a tool for controlling coccidiosis in broilers and replacement pullets, blunting the ever-present threat of economic disaster from intestinal protozoa. The compound lets poultry producers cut back on therapeutic drugs and coping strategies that hurt both animal welfare and margin. Some veterinarians deploy it in rotation programs with other coccidiostats, or in shuttle programs, to slow down the advance of drug-resistant Eimeria strains. A few nations have approved its use in other livestock, but most stick to intensive poultry. Its affordability and record of reducing clinical disease have kept it on authorized lists despite broader moves toward antibiotic-free agriculture. Debate simmers in the EU about phasing out all ionophores, reflecting consumer concern about chemical residues even as industry points to the real threat of untreatable outbreaks in crowded barns.
Researchers keep close watch for new resistance patterns in coccidia, using field studies and genetic typing to spot farms where maduramicin no longer keeps disease at bay. Ongoing projects try to unravel the precise mode of ion transport and protozoal death, drawing on molecular biology tools unimagined in the 1980s. University labs publish on improved production yields through bioprocess tweaks, zeroing in on both upstream strain improvement and downstream crystal engineering. Cross-disciplinary teams study impacts on gut microflora, looking out for shifts that might link to later health problems or growth rates in livestock. Agritech start-ups try to piggyback off the maduramicin platform with “greener” analogues or delivery systems, nudging the field toward sustainability without losing sight of outbreak control.
Animal trials, accidental poisonings, and controlled lab studies have mapped out a complex risk profile. Maduramicin shows strong selectivity: used at labeled rates, it clears coccidial infections in chicken flocks with limited side effects, but even modest overdosing triggers significant signs of intoxication in non-target animals. Horses, in particular, display remarkable sensitivity, with fatality from unintended exposure well documented. In people, accidental exposure to high-concentration forms or dust can trigger nausea, headaches, and more serious neurological signs with enough contact. Residues in poultry meat stay low if withdrawal times are respected, according to international monitoring programs. The fine line between therapeutic value and acute toxicity leads regulators to insist on batch testing, validated analytical tools, and public reporting of any incident—no shortcuts tolerated.
The road ahead for maduramicin ammonium runs through innovation and mounting ethical questions. On one hand, demand from large-scale poultry operations in Asia, Africa, and South America drives continued production growth, especially as new markets push for reliable food supplies with lower disease losses. Drug resistance grows as a shadow, spurring both more sophisticated management protocols and investment in combination therapies. Public pressure for reduced chemical use and natural farming raises the bar for residue limits and traceability. Work continues on feed formulations that combine maduramicin with probiotics or vaccines, aiming to push risk and drug load lower. Some countries set timelines for phasing out all ionophores, betting on advances in genetics and barn management to keep animals safe without modern chemistry. The next few years will test whether alternatives can deliver the same dependability or whether maduramicin, with some tweaks, remains a bedrock for disease management in farming systems wrestling with the real constraints of profit, animal health, and consumer expectation.
Maduramicin Ammonium plays a role in modern animal farming, especially with chickens and turkeys. Farmers add it to feed as a coccidiostat—a mouthful, but in simple terms, it helps prevent coccidiosis. This disease often sweeps through barns, hits the birds’ guts, and can take down a flock fast. Losing birds to sickness isn't just about numbers; these are people’s livelihoods and part of what fills our dinner tables.
Coccidiosis hurts more than just the birds. Sick animals eat less, grow slower, and never reach their full weight. That means less chicken in the market, unstable prices, and more pressure on a farmer already stretched thin. Flocks kept healthy are more productive and, not surprisingly, less likely to need emergency treatment with antibiotics. Using products like Maduramicin to head off disease can also mean less antibiotic resistance—a win for everyone, since resistant bugs can threaten both animals and people.
No medication is perfect. Improper use of Maduramicin can build up in the birds or the environment. At high enough doses, it turns toxic. That’s why feed makers and farmers keep records, and people in white coats run residue checks. Regulations set clear safety limits. Anyone raising chickens for food knows the rulebook on withdrawal periods—stopping the feed with Maduramicin early enough so residues clear out before birds go to market. These rules protect the people who eat the meat, and farmers have no interest in breaking them.
Many people want fewer additives in food production. The industry keeps searching for that balance: keeping birds healthy, food affordable, and minimizing drug leftovers. Maduramicin rolling out in a barn isn’t a cheat or shortcut—it’s a layer in a bigger plan. Clean barns, good airflow, new vaccines, and solid nutrition all work alongside products like this to keep infections in check.
Relying on any single medicine too much can backfire. Companies and universities spend time and money hunting for better answers. Some farmers try rotating coccidiostats; others push for probiotic feed supplements or different ways to boost bird immunity. Still, for many operations, pulling Maduramicin out of the mix too soon could open the door to more outbreaks, more losses, and eventually, more cost.
People want to trust their food, and rightfully so. Transparency, regular safety checks, and ongoing research go a long way. Sharing with consumers how and why certain feed medications get used takes some of the mystery out of what lands on the plate. The entire process—farm to fork—relies on tools like Maduramicin, but it never stands alone. Listening to farmers, scientists, and buyers helps push food production toward better solutions for everyone at the table.
Raising healthy livestock calls for careful management of disease, especially among chickens and turkeys grown for meat. Coccidiosis, a parasitic illness, causes big losses on poultry farms. Maduramicin ammonium steps in as a strong ally against this problem. It blocks the life cycle of coccidia, easing the weight on both farmers and birds.
Most farm folks add maduramicin ammonium straight into the animals’ feed. Mixing starts at the feed mill, where the compound combines with corn, soybean meal, and other ingredients. Feed manufacturers measure out amounts with real care, following strict instructions based on safety and science. Too little in the mix won’t handle the parasites; too much spells toxicity.
No one tosses maduramicin into water troughs or delivers it through an injection. The digestive tract acts as the gatekeeper—when mixed with feed, maduramicin travels right to the gut, where coccidia parasites cause trouble. The timing matches the birds’ daily feeding habits, so medication keeps a steady presence. Most farmers use this approach from early in the birds’ lives and stop adding it before slaughter, following the withdrawal period to avoid any residues in meat.
Feed inclusion rates rely on the animal’s age, species, and the layout of the poultry house. Young chicks and turkeys, not yet toughened by exposure, stay most vulnerable. Farmers track how much each flock eats to make sure the medication lines up with their intake. If a batch of feed holds uneven doses, some birds end up with too much or too little—opening the door to either health risks or disease outbreaks.
Over the years, feed mixing equipment has gotten better at measuring and distributing additives. Sophisticated blenders and computer-controlled batching systems make it easier to trust every mouthful. Of course, behind all those tools stands a person—farm staff checking numbers, testing samples, watching for any errors.
Maduramicin ammonium does a good job when used properly, but it’s not a ‘set-and-forget’ solution. Chickens and turkeys handle this medicine well, though other farm animals like horses face more danger. Even small traces in the wrong feed can harm or kill the wrong species. Farmers store medicated feed and non-medicated feed apart, label bags, and maintain proper record keeping.
Regulators keep a close eye on how the industry uses coccidiostats like maduramicin. In my years working with producers and veterinarians, I’ve seen routine feed sampling, official audits, and constant training. Feed mills test batches for dosage accuracy and contamination. Flock health isn’t just about pumping in medication—it comes from combining good biosecurity, sound nutrition, and practical farm know-how.
One problem that keeps showing up is drug resistance. Parasites sometimes outsmart single strategies over time, sticking around even in treated flocks. Many producers switch between different coccidiostats or combine treatments with vaccines and probiotics. This rotation helps slow resistance, stretching out the usefulness of existing drugs.
Farmers and animal feed manufacturers keep facing new pressures—from consumers, regulators, and the realities of disease. Focusing on safe and correct administration makes a big difference, not just for profit, but for the health of people, animals, and the land itself.
Maduramicin ammonium plays a role in controlling coccidiosis, a disease that can devastate poultry flocks. Anyone working with animals knows the tightened budgets in agriculture, and keeping birds healthy means more food hits tables at a fair price. Feed producers have turned to additives like maduramicin to keep birds disease-free, but like with any powerful tool, knowing the risks matters just as much as celebrating the benefits.
The main concern comes from overdosing. Chicks and older birds can both get sick if they take in too much. Early warning signs kick in pretty fast—reduced appetite, lack of coordination, drooping wings, and severe muscle weakness in heavier overdoses. I’ve seen birds with these symptoms up close during a farm visit, and recovery isn’t simple. Lab data backs this up: high doses damage heart and skeletal muscle tissue, which can lead to sudden death, especially when temperatures heat up or birds feel stressed.
Farmers also worry about residue in edible tissues. Left unchecked, excess maduramicin builds up in organs—especially the liver—which means serious food safety checks have to stay in place. Globally, food agencies have mapped out “withdrawal periods” before slaughter, all in an effort to keep public health safe. In my experience, folks outside the farm never see these safety nets, but without them, drugs like maduramicin would bring real risk to people up and down the food chain.
It’s not only birds that feel the impact. Accidental exposure for farm workers handling feed dust can cause skin and eye irritation. I’ve heard stories from feed mill employees about rashes or red, watering eyes after handling medicated feed without gloves or masks. For cats and dogs that sneak into barns, just a small dose can bring on tremors, drooling, vomiting, and even fatal heart complications. Regulators keep birds and humans in mind when they look at any new study, but anyone on a farm knows that animals don’t read warning signs.
Long-term use has a way of creating problems down the line. Birds’ gut parasites start getting resistant, making the medicine less effective year by year. Once that happens, the cost goes up, and disease risk climbs. Also, farms that let droppings pile up outside don’t just invite stench complaints—maduramicin seeps into soil and water, with studies confirming its toxicity for earthworms and aquatic life. I once saw a research demo where even low levels killed off tank snails in a matter of days.
Weighing the good and bad takes more than a chemistry report. Smart farms rotate medications, try probiotics, or use vaccines, all to prevent overreliance on any one drug. Routine checks, protective gear, and respecting withdrawal periods work together to lower risk. The science keeps moving, offering tools that balance animal health, food safety, and the environment. Staying informed and following best practices isn’t just a rule—it keeps real people, animals, and landscapes healthy.
Maduramicin Ammonium shows up in a lot of feed as a coccidiostat, mostly for poultry. It’s built to fight parasites, offering protection that keeps animals healthier and production losses lower. Here’s the kicker: as useful as this drug is, people worry about traces staying in meat or eggs when those animals finally reach the consumer’s table. Regulatory agencies around the world have stepped up to set a withdrawal period for Maduramicin. That means farmers have to stop feeding it to their animals a set number of days before slaughter, so residues have time to drop below safety limits.
The whole idea behind withdrawal periods roots itself in food safety. Consumers today want—and deserve—meat that’s free of harmful drug residues. This isn’t some distant problem, either. Data from the U.S. Food and Drug Administration and European Food Safety Authority both show that if animals are slaughtered too soon after medicating, residues can show up in the edible tissues. Even low levels can create problems, such as allergic reactions or the slow march of antimicrobial resistance. It only takes a few high-profile recalls to shake public trust or slice through the bottom line for food producers.
Regulations spell out a specific withdrawal period for Maduramicin Ammonium. In most countries, birds can’t go to the processor for at least five days after the last dose. Some places push for at least seven days. I remember times in the field when one missed entry in a feed chart meant the clock restarted—nobody wanted to risk a failed residue test. Producers take these timelines seriously because failing one test means hitting pause on hundreds or thousands of animals until more samples clear the lab. For egg-laying hens, the guidelines become stricter, since eggs show residues fast. Most standards ban its use in layers whose eggs are sold for human food.
Mixing medication into animal feed isn’t the hard part. The tricky areas pop up with recordkeeping and timing. It doesn’t take much—an employee misunderstanding the feed schedule or a delivery truck showing up late—to throw off that carefully planned window. Out in real barns, farmers use color-coded charts and clear handoffs at shift changes. Gaps still show up, and sometimes the only fix is dumping out feed bins and starting over, losing money and wasting time. This isn’t theoretical—several families in the business have had to call off shipments because of a simple miscommunication.
Solutions already exist, but there’s room for improvement. Digital logging can track exactly which group of birds got their final dose and calculate a safe slaughter date. Some farms have moved to integrated management software, reducing human error and making audits faster. Training goes a long way. New workers learn not only about animal care, but why counting days matters so much. Regulators stay on the ground, spot-checking records and tissue samples to catch mistakes before they hit the consumer market. I’ve seen a cooperative effort between farmers and authorities actually build trust—and give better results than finger-pointing ever did.
With so many eyes on food safety, the withdrawal period for Maduramicin Ammonium isn’t optional. It stands as a critical step between an effective tool on the farm and a safe product at the grocery store. Farmers benefit by staying ahead of regulations and keeping their reputation clean. In the end, everyone shares the goal: healthy animals, safe food, and peace of mind at the dinner table.
Look across the world’s broiler houses and you’ll spot the same problem: coccidiosis causing havoc with young chickens. Maduramicin Ammonium remains approved for use almost entirely in broiler chickens, both in the United States and the European Union. Turkeys, laying hens, ducks, or other minor food animal species do not get the green light for this compound. Regulatory authorities aimed to keep its use to growing chickens raised specifically for meat, and they have their reasons.
This limitation comes from a combination of practical experience and solid scientific trials. Broilers face relentless pressure from Eimeria parasites. Maduramicin Ammonium can knock down parasite development, stop birds from dropping feed efficiency or dying, and help farms avoid big financial losses. Laying hens and turkeys follow a different timeline, and the safety margin for maduramicin thins out for them. Prolonged exposure—typical for laying birds—raises the risk of toxicity and unwanted drug residues in eggs or meat. These risks explain why regulatory bodies keep it out of other animals' diets. After decades of monitoring, regulators stick to the stance that meat chickens are the only safe bet.
No one can simply add maduramicin to every type of chicken ration. Rules tie strictly to age, withdrawal periods before slaughter, and specific dosage ranges. The FDA and the European Medicines Agency each list exact grams-per-ton feed rates and make withdrawal before slaughter mandatory. Failing to observe these rules causes residue in processed meat, which opens the door to export bans or recalls—something chicken processors dread. No loopholes for off-label treatment or small-scale mixing slip by either; regulations aim for both large and small operators to play by the same book.
Poultry farmers know what happens when coccidiosis spreads unchecked. Stunted growth, lost income, and dead birds can ruin whole flocks in a matter of days. Maduramicin Ammonium’s approval gives them one useful, predictable tool. By sticking to broilers alone, regulators try to strike a balance between tackling disease and maintaining food safety. Consumers want chicken that stays affordable and safe from drug residues. Farmers want options against disease, but clear guidance helps them protect their own operations from future regulatory crackdowns.
Calls continue for new anticoccidial tools or more alternative strategies, like vaccines and probiotics. Animal scientists and food safety specialists often raise the need for careful rotation and surveillance, since overreliance on any one compound triggers resistance. If resistance to maduramicin climbs, which already started happening in certain regions, producers have to look at other controls, cleanout routines, and possibly more investment in vaccine technology. From both science and common sense, throwing the same answer at every problem rarely works forever.
Most of the world’s mass-market chicken crosses through this landscape. Consumers, veterinarians, and farmers all share a stake. Approvals stay tight for a reason, farmers face more paperwork, and consumers can trust the food chain a little more knowing there’s an evidence-based approach behind every feed additive.
| Names | |
| Preferred IUPAC name | Ammonium (2R)-2-[(1R,2S,3S,5R,7R,8R,9S,11R,13R,14S,17R)-6-[(2S,3S,5S,6R)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]oxy-3,5,7,9,11,13,17-heptamethyl-16-oxo-4,15-dioxapentacyclo[13.3.1.0¹,⁹.0²,⁸.0¹¹,¹⁴]nonadec-3-yl]acetate |
| Other names |
Maduramycin ammonium alpha Maduramycin ammonium β Maduramycin ammonium Maduramicin ammonium alpha Maduramicin ammonium salt |
| Pronunciation | /ˌmæd.jʊˈræm.ɪ.sɪn əˈmɒn.i.əm/ |
| Identifiers | |
| CAS Number | [155090-83-8] |
| Beilstein Reference | 136805 |
| ChEBI | CHEBI:8060 |
| ChEMBL | CHEMBL2106053 |
| ChemSpider | 59334530 |
| DrugBank | DB11450 |
| ECHA InfoCard | RTECS: AG7526000 |
| EC Number | EC 231-801-5 |
| Gmelin Reference | 1422125 |
| KEGG | C13875 |
| MeSH | D000409 |
| PubChem CID | 6433118 |
| RTECS number | BQ9625000 |
| UNII | WX2F89T59E |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C47H83NO17 |
| Molar mass | 934.1 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.98 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 0.93 |
| Acidity (pKa) | 13.14 |
| Basicity (pKb) | 3.31 |
| Dipole moment | 2.89 D |
| Pharmacology | |
| ATC code | QH92AX90 |
| Hazards | |
| Main hazards | May be fatal if swallowed, inhaled, or absorbed through skin; causes damage to organs; very toxic to aquatic life. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | Harmful if swallowed. Toxic to aquatic life with long lasting effects. |
| Precautionary statements | Do not breathe dust/fume/gas/mist/vapours/spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection. |
| NFPA 704 (fire diamond) | 2-3-2 |
| Lethal dose or concentration | LD₅₀ (oral, rat): 28 mg/kg |
| LD50 (median dose) | LD50 (median dose): 36 mg/kg (rat, oral) |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 5.0‒7.0 mg/kg |
| Related compounds | |
| Related compounds |
Salinomycin Monensin Narasin Lasalocid Semduramicin Nicarbazin |
